MedPath
HSA Product

Toujeo SoloStar 300 units/ml solution for injection in a pre-filled pen

Product approved by Health Sciences Authority (SG)

Basic Information

Toujeo SoloStar 300 units/ml solution for injection in a pre-filled pen

INJECTION, SOLUTION

Regulatory Information

SIN15138P

December 14, 2016

Prescription Only

Therapeutic

SUBCUTANEOUS

August 10, 2023

May 30, 2025

XA10AE04

Company Information

SANOFI-AVENTIS SINGAPORE PTE. LTD.

SANOFI-AVENTIS SINGAPORE PTE. LTD.

Active Ingredients

Insulin glargine

Strength: 300 Units/ml

Detailed Information

Contraindications

**4.3 Contraindications** Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_.

Indication Information

**4.1 Therapeutic indications** Treatment of diabetes mellitus in adults, adolescents and children from the age of 6 years.

© Copyright 2025. All Rights Reserved by MedPath